Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 4
2006 5
2007 2
2008 6
2009 3
2010 1
2011 12
2012 2
2013 2
2014 2
2016 5
2017 5
2018 2
2019 2
2020 3
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.
Moreno-Manuel A, Jantus-Lewintre E, Simões I, Aranda F, Calabuig-Fariñas S, Carreras E, Zúñiga S, Saenger Y, Rosell R, Camps C, Lozano F, Sirera R. Moreno-Manuel A, et al. Among authors: sirera r. Transl Lung Cancer Res. 2020 Aug;9(4):1074-1083. doi: 10.21037/tlcr-19-445. Transl Lung Cancer Res. 2020. PMID: 32953486 Free PMC article.
Oncogenic role of arsenic exposure in lung cancer: A forgotten risk factor.
Soza-Ried C, Bustamante E, Caglevic C, Rolfo C, Sirera R, Marsiglia H. Soza-Ried C, et al. Among authors: sirera r. Crit Rev Oncol Hematol. 2019 Jul;139:128-133. doi: 10.1016/j.critrevonc.2019.01.012. Epub 2019 Jan 25. Crit Rev Oncol Hematol. 2019. PMID: 30878179 Review.
Exosomes genetic cargo in lung cancer: a truly Pandora's box.
Reclusa P, Sirera R, Araujo A, Giallombardo M, Valentino A, Sorber L, Bazo IG, Pauwels P, Rolfo C. Reclusa P, et al. Among authors: sirera r. Transl Lung Cancer Res. 2016 Oct;5(5):483-491. doi: 10.21037/tlcr.2016.10.06. Transl Lung Cancer Res. 2016. PMID: 27826529 Free PMC article. Review.
dPCR application in liquid biopsies: divide and conquer.
Moreno-Manuel A, Calabuig-Fariñas S, Obrador-Hevia A, Blasco A, Fernández-Díaz A, Sirera R, Camps C, Jantus-Lewintre E. Moreno-Manuel A, et al. Among authors: sirera r. Expert Rev Mol Diagn. 2021 Jan;21(1):3-15. doi: 10.1080/14737159.2021.1860759. Epub 2020 Dec 30. Expert Rev Mol Diagn. 2021. PMID: 33305634
FGFR a promising druggable target in cancer: Molecular biology and new drugs.
Porta R, Borea R, Coelho A, Khan S, Araújo A, Reclusa P, Franchina T, Van Der Steen N, Van Dam P, Ferri J, Sirera R, Naing A, Hong D, Rolfo C. Porta R, et al. Among authors: sirera r. Crit Rev Oncol Hematol. 2017 May;113:256-267. doi: 10.1016/j.critrevonc.2017.02.018. Epub 2017 Mar 23. Crit Rev Oncol Hematol. 2017. PMID: 28427515 Review.
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.
Malapelle U, Sirera R, Jantus-Lewintre E, Reclusa P, Calabuig-Fariñas S, Blasco A, Pisapia P, Rolfo C, Camps C. Malapelle U, et al. Among authors: sirera r. Expert Rev Mol Diagn. 2017 Mar;17(3):209-215. doi: 10.1080/14737159.2017.1288568. Epub 2017 Feb 9. Expert Rev Mol Diagn. 2017. PMID: 28129709 Review.
EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.
Herreros-Pomares A, Aguilar-Gallardo C, Calabuig-Fariñas S, Sirera R, Jantus-Lewintre E, Camps C. Herreros-Pomares A, et al. Among authors: sirera r. Crit Rev Oncol Hematol. 2018 Jun;126:52-63. doi: 10.1016/j.critrevonc.2018.03.006. Epub 2018 Mar 21. Crit Rev Oncol Hematol. 2018. PMID: 29759567 Review.
53 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page